Gilead Sciences Beats Street and Sees Sovaldi Sales Double - Presented by: The Aol. On Network

Gilead Sciences shares rose sharply in after-hours trading on Wednesday after the company reported second quarter results which surpassed analyst forecasts. The biotech company posted profits of $2.23 a share, far higher than the $1.79 analysts had been expecting. Revenue came in at $6.53 billion, that was also better than estimates. Gilead reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago because of its Sovaldi sales. Sovaldi



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 15.15 0.28 ▼ 1.81%
PBR $ 6.01 0.39 ▼ 6.09%
AAPL $ 117.16 1.74 ▼ 1.46%
MSFT $ 40.40 1.61 ▼ 3.83%
TVIX $ 3.54 0.55 ▲ 18.39%
T $ 32.92 0.04 ▼ 0.12%
GE $ 23.89 0.19 ▼ 0.79%
SIRI $ 3.55 0.04 ▼ 1.11%

As of 1/30/2015, 04:15 PM
More Most Active